Nassar AH, Jayakrishnan R, Feng J, Shepherd F, et al. Consolidation ALK Tyrosine Kinase Inhibitors versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK+ Non-Small Cell Lung Cancer. J Thorac Oncol 2024 Sep 9:S1556-0864(24)02265.
PMID: 39260522